Skip to search formSkip to main contentSkip to account menu

PD 180988

Known as: CI-1034, CI1034, PD180988 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Liver safety evaluation of endothelin receptor antagonists using HepatoPac®: A single model impact assessment on hepatocellular health, function and bile acid disposition
Marketed (bosentan, ambrisentan) and discontinued (sitaxsentan, CI‐1034) endothelin receptor antagonists were examined in the… 
2007
2007
Acute coronary artery injury in dogs following administration of CI-1034, an endothelin A receptor antagonist
The objective of this study was to characterize acute coronary artery injury evoked by the endothelin A receptor (ETAR… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)